Browse by Authors and EditorsNumber of items: 5. O'Tuathaigh, C.M.P., Moran, P.M., Zhen, X.C. and Waddington, J.L. (2017) Translating advances in the molecular basis of schizophrenia into novel cognitive treatment strategies. British Journal of Pharmacology, 174 (19). pp. 3173-3190. ISSN 1476-5381 O'Tuathaigh, C.M.P., Mathur, N., O'Callaghan, M.J., MacIntyre, L., Harvey, R., Lai, D., Waddington, J.L., Pickard, B.S., Watson, D.G. and Moran, Paula M. (2017) Specialised information processing deficits and distinct metabolomics profiles following TM-domain disruption of Nrg1. Schizophrenia Bulletin . ISSN 1745-1701 Moran, Paula M., Stokes, Jennifer, Marr, Julia, Bock, Gavin, Desbonnet, Lieve, Waddington, J.L. and O'Tuathaigh, C.M.P. (2016) Gene × environment interactions in schizophrenia: evidence from genetic mouse models. Neural Plasticity, 2016 . 2173748/1- 2173748/23. ISSN 1687-5443 O'Callaghan, M.J., Bay-Richter, C., O’ Tuathaigh, Colm M.P., Heery, David M., Waddington, J.L. and Moran, Paula M. (2014) Potentiation of latent inhibition by haloperidol and clozapine is attenuated in Dopamine D2 receptor (Drd-2) deficient mice: Do antipsychotics influence learning to ignore irrelevant stimuli via both Drd-2 and non-Drd-2 mechanisms? Journal of Psychopharmacology, 28 (10). pp. 973-977. ISSN 1461-7285 Bay-Richter, C., O'Callaghan, M.J., Mathur, N., O'Tuathaigh, C.M.P., Heery, D.M., Fone, Kevin C.F., Waddington, J.L. and Moran, P.M. (2013) D-amphetamine and antipsychotic drug effects on latent inhibition in mice lacking dopamine D2 receptors. Neuropsychopharmacology, 38 (8). pp. 1512-1520. ISSN 1740-634X |